BioLife Solutions, Inc. (BLFS) investor relations documents from the company's IR site: 1 presentation, 4 press releases; latest deck 2026-02-26. Read in-app with summaries. First-party data.
https://investors.biolifesolutions.com/image/2025_BLFS_Investor_Presentation_vF_2026-02-26.pdf — BioLife Solutions is a provider of biopreservation and cell processing tools, reporting $96M in FY 2025 revenue with a 65% gross margin.
| Published | Type | Document |
|---|---|---|
| 2026-08-06 | Press release | BioLife Solutions Reports Second Quarter 2026 Financial Results |
| 2026-04-21 | Press release | Press release |
| 2026-02-26 | Press release | BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations |
| 2026-02-26 | Presentation | https://investors.biolifesolutions.com/image/2025_BLFS_Investor_Presentation_vF_2026-02-26.pdf |
| 2026-02-17 | Press release | BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026 |
BLFS overview · BLFS earnings · BLFS financials · BLFS KPIs · BLFS ownership · BLFS peers · BLFS filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.